Artikler og videnskaben bag – Preeclampsia Prevention in Denmark

Artikler og videnskaben bag

Her findes et udvalg af internationale studier, som beskriver udvikling og afprøvning af screening for svangerskabsforgiftning

Nedenfor findes links til et udvalg af de videnskabelige studier, som har vist, at screening for svangerskabsforgiftning er effektiv og sikker.

Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. N. O’ Gorman et al. Ultrasound Obstet Gynecol 2017

Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. M. Y. Tan et al., Ultrasound Obstet Gynecol 2018

Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. M. Y. Tan et al., Ultrasound Obstet Gynecol 2018

The American College of Obstetrics and Gynecologists Practice Bulletin on Gestational Hypertension and Preeclampsia

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. N. O’ Gorman et al., Am J Obstet Gynecol, 2016.

The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Poon et al., Int J Gynecol Obstet, 2019.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. Rolnik et al. N Engl J Med 2017 Aug 17;377(7):613-622.

Læs mere om den danske evidens

PREPRED-projektet

Charlotte Ekelund, overlæge, ph.d.,
Afdeling for Gynækologi, Fertilitet og Fødsler, Rigshospitalet

Line Rode, overlæge ph.d.,
Afdeling for Klinisk Biokemi, Rigshospitalet

Iben Riishede, læge, ph.d.,
Afdeling for Gynækologi, Fertilitet og Fødsler, Rigshospitalet

Teamet bag

kontakt@prepred.dk

Instagram: prepred_dk